{'fraction_non_alphanumeric': 0.011325028312570781, 'fraction_numerical': 0.0011325028312570782, 'mean_word_length': 5.90625, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Malignant pericardial effusion and pericardial tumor involvement secondary to cervical cancer.

BACKGROUND
Antemortem discovery of a malignant pericardial effusion secondary to cervical cancer is uncommon and management should focus on symptom control.


CASE
A patient was diagnosed with widely metastatic cervical cancer following a simple hysterectomy for presumed benign etiology. Sixteen months later, she was diagnosed with pericardial tumor involvement and a malignant pericardial effusion resulting in severe dyspnea. The patient underwent a pericardial window procedure that temporarily alleviated her symptoms. She again developed symptoms 2 weeks following the procedure and ultimately elected supportive care.


CONCLUSION
Malignant pericardial effusion is a challenging clinical scenario. Although multiple treatment options exist, prognosis is poor and usually limited.